Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-16-014315
Filing Date
2016-12-23
Accepted
2016-12-23 17:01:13
Documents
60
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K ctxr_10k.htm 10-K 757405
2 SUBSIDIARIES ctxr_ex21.htm EX-21 2035
3 CONSENT ctxr_ex23.htm EX-23 1587
4 CERTIFICATION ctxr_ex311.htm EX-31.1 11227
5 CERTIFICATION ctxr_ex321.htm EX-32.1 3864
  Complete submission text file 0001477932-16-014315.txt   3772981

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctxr-20160930.xml EX-101.INS 663477
7 XBRL TAXONOMY EXTENSION SCHEMA ctxr-20160930.xsd EX-101.SCH 55059
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctxr-20160930_cal.xml EX-101.CAL 43399
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctxr-20160930_def.xml EX-101.DEF 125846
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctxr-20160930_lab.xml EX-101.LAB 286358
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctxr-20160930_pre.xml EX-101.PRE 226176
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-55532 | Film No.: 162069345
SIC: 2834 Pharmaceutical Preparations